Global Patent Protection

Protected Innovation. Global Vision.

At GyneConcepts, innovation is at the heart of everything we do.

The Privacy Pap Smear (PPS) represents years of research, development, engineering, and commitment to advancing women's healthcare. To protect this breakthrough technology and support its future expansion, GyneConcepts has built a strong international patent portfolio covering key global markets.

As the world's first patented cervical cell collection device designed for self-administration, the Privacy Pap Smear is protected by intellectual property rights across multiple countries and regions.

These patents help safeguard the unique technology behind the PPS while supporting our long-term mission of expanding access to cervical health screening worldwide.

The World's First Patented

Self-Administered Cervical Cell Collection Device with CE mark approval

The Personal Pap Smear™ (PPS) was developed to address a challenge that has existed for decades: How do we help more women participate in cervical cancer screening?

For many women, routine screening is delayed or avoided because of:

The PPS was designed to help remove these obstacles by allowing women to self-administer cervical cell collection in the privacy of their own home or within a healthcare setting.

Protecting this innovation through patents helps ensure that the technology can continue to evolve and reach more women around the world.

United States Patent Protection

GyneConcepts holds two issued United States patents protecting the Personal Pap Smear™ (PPS) technology.

Together, these patents establish the foundation of GyneConcepts' intellectual property portfolio.

Expanding Access Through Innovation

The current GyneConcepts patent estate covers regions representing more than:

621 Million Women Ages 25–64

Across North America, Europe, Africa, and Asia-Pacific regions.

This global footprint reflects the significant opportunity to improve awareness, participation, and accessibility in cervical cancer screening. While every healthcare market is unique, the need for convenient and patient-centered screening solutions remains consistent around the world.

Innovation Designed Around Women

The Privacy Pap Smear was never created simply as a product. It was created as a response to a problem. For decades, women have told healthcare providers that cervical cancer screening can feel: Uncomfortable, Embarrassing, Inconvenient, Difficult to prioritize.

GyneConcepts listened.

The result was a patented technology designed to give women greater flexibility, privacy, and control over an important aspect of their preventive healthcare. That commitment continues to guide every stage of our innovation journey.

International Patent Coverage

GyneConcepts has strategically expanded patent protection into key global markets where improved access to cervical cancer screening may have a meaningful impact on women's health.

In addition to these countries, the Privacy Pap Smear is protected through European patent validations in several major markets. These validations support GyneConcepts' long-term commitment to advancing women's healthcare across Europe and expanding access to innovative cervical health screening technologies.

Why Patents Matter

Patents do more than protect inventions. They encourage innovation.

•  Research and development
• Product improvements
• Clinical evaluation
• Manufacturing capabilities
• Global expansion
• Future women's health innovations

Strong patent protection helps ensure that groundbreaking ideas can continue to grow and evolve into solutions that benefit patients worldwide.

Supporting a Global Women's Health Mission

Many of the barriers that prevent screening are universal:

By protecting the PPS internationally, GyneConcepts is creating a foundation for future growth that may help bring innovative cervical health solutions to women across multiple healthcare systems and populations.

Looking Toward the Future

Our vision extends beyond patents and technology. We envision a future where: More Women Get Screened, More Cervical Cancers Are Prevented, More Lives Are Protected Through Early Detection, Women's Healthcare Becomes More Accessible Worldwide. The global patent protection surrounding the Privacy Pap Smear helps create a foundation for achieving that vision. As research, clinical evaluation, and product development continue, GyneConcepts remains focused on expanding opportunities for women to participate in potentially life-saving screening.